-
Rouse Atkins posted an update 21 hours, 50 minutes ago
05). However, the rs4485469 SNP was found to be borderline significant between the patient groups with and without BRCA1 or BRCA2 mutations (p = 0.059). In patients with BRCA1 or BRCA2 pathogenic variations living in the Trakya region of Turkey, we could not determine the relationship between TNFRSF11 SNPs with breast cancer risk.Propofol…[Read more]
-
Rouse Atkins posted an update 1 day, 22 hours ago
To evaluate the clinical performance of a deep learning (DL)-based method for brain MRI exams with reduced gadolinium-based contrast agent (GBCA) dose to provide better understanding of the readiness and limitations of this method.
Eighty-three consecutive patients (from March 2019 to August 2019) who underwent brain contrast-enhanced (CE)…[Read more]
-
Rouse Atkins posted an update 2 days, 15 hours ago
We have previously shown that the Kunitz-type serine protease inhibitor Spint1a, also named Hai1a, is required in the zebrafish embryonic epidermis to restrict the activity of the type II transmembrane serine protease (TTSP) Matriptase1a/St14a, thereby ensuring epidermal homeostasis. A closely related Kunitz-type inhibitor is Spint2/Hai2, which in…[Read more]
-